Surgery May Be Best for Irregular Heartbeat in Young
WEDNESDAY, Sept. 22 (HealthDay News) -- Young people with the
kind of irregular heartbeat known as atrial fibrillation may be
better off undergoing surgery to fix the problem instead of taking
medication first, a new study suggests.
Blood Thinner OK for Superficial Leg Clots: Study
WEDNESDAY, Sept. 22 (HealthDay News) -- A blood-thinning drug
could help some patients with superficial-vein thrombosis avoid
more serious blood clots, a new study suggests. But experts
question whether the benefit is worth the drug's high price.
Consumer Activists Want Modified Salmon to Be Labeled
WEDNESDAY, Sept. 22 (HealthDay News) -- Opponents of genetically
modified salmon, as well as consumer activists and
environmentalists, told a U.S. Food and Drug Administration
advisory panel Tuesday that it would be irresponsible not to
require labels on the fish if it is approved for humans to eat.
FDA Approves 1st Oral Drug to Reduce MS Relapses
WEDNESDAY, Sept. 22 (HealthDay News) -- The U.S. Food and Drug
Administration on Wednesday approved the first oral drug to reduce
relapses of multiple sclerosis, the nervous system disorder that
has traditionally been treated with injectable drugs.
Gilenya Approved for Relapsing MS
WEDNESDAY, Sept. 22 (HealthDay News) -- Gilenya (fingolimod) has
been approved by the U.S. Food and Drug Administration to reduce
relapses and delay disability progression in people with relapsing
forms of multiple sclerosis.
Novel Rheumatoid Arthritis Drug Shows Early Promise
WEDNESDAY, Sept. 22 (HealthDay News) -- A new targeted
medication for rheumatoid arthritis (RA) may benefit patients with
this chronic autoimmune disease who aren't adequately helped by
standard RA drug therapy, researchers say.